Standpoint Research Upgrades United Therapeutics Corp. (UTHR) to Buy
Tweet Send to a FriendGet Alerts UTHR Hot Sheet
Price: $67.61 --0%
Rating Summary:
3 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Rating Summary:
3 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Trade UTHR Now!
Standpoint Research upgraded United Therapeutics Corp. (NASDAQ: UTHR) from Hold to Buy with a price target of $65.00.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $53.79 yesterday, with a 52 week range of $40.34-$59.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $53.79 yesterday, with a 52 week range of $40.34-$59.00.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Upgrades Pacific Sunwear of California (PSUN) to Buy
- RBC Capital Upgrades Pandora (P) to Outperform
- Piper Jaffray Upgrades Gordmans Stores (GMAN) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Standpoint Research
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
